Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessing the epithelial-to-mesenchymal plasticity in a small cell lung carcinoma (SCLC) and lung fibroblasts co-culture model. | Front Mol Biosci | 2023 | 36936987 | PubTator, text mining | PubMed |
| The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders. | Front Immunol | 2023 | 36936905 | PubTator, text mining | PubMed |
| Effect of acupuncture on neuroinflammation in animal models of Alzheimer's disease: A preclinical systematic review and meta-analysis. | Front Aging Neurosci | 2023 | 36936500 | PubTator, text mining | PubMed |
| Innate immune biology in age-related macular degeneration. | Front Cell Dev Biol | 2023 | 36926522 | PubTator, text mining | PubMed |
| C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia. | Blood Adv | 2023 | 36920779 | PubTator, text mining | PubMed |
| Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial. | Schizophr Bull | 2023 | 36916850 | PubTator, text mining | PubMed |
| Screening of potential pain genes in pancreatic ductal adenocarcinoma (PDAC) based on bioinformatics methods. | J Gastrointest Oncol | 2023 | 36915423 | PubTator, text mining | PubMed |
| Case report: Immune profiling links neutrophil and plasmablast dysregulation to microvascular damage in post-COVID-19 Multisystem Inflammatory Syndrome in Adults (MIS-A). | Front Immunol | 2023 | 36911724 | PubTator, text mining | PubMed |
| The role of gene encoding collagen secretion protein (SERPINH1) in the pathogenesis of a hypermobile type of Ehlers-Danlos syndrome. | Postepy Dermatol Alergol | 2023 | 36909907 | PubTator, text mining | PubMed |
| Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy. | Mediterr J Hematol Infect Dis | 2023 | 36908864 | PubTator, text mining | PubMed |
| Molecular Simulation Study on the Interaction between Porcine CR1-like and C3b. | Molecules | 2023 | 36903431 | PubTator, text mining | PubMed |
| How to Best Protect Kidneys for Transplantation-Mechanistic Target. | J Clin Med | 2023 | 36902572 | PubTator, text mining | PubMed |
| Proteotranscriptomic Discrimination of Tumor and Normal Tissues in Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 36901940 | PubTator, text mining | PubMed |
| The Complement System in Kidney Transplantation. | Cells | 2023 | 36899927 | PubTator, text mining | PubMed |
| Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular Degeneration. | Cells | 2023 | 36899910 | PubTator, text mining | PubMed |
| SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb. | Blood Adv | 2023 | 36897252 | PubTator, text mining | PubMed |
| Quincke's disease: an unusual pathology. | J Surg Case Rep | 2023 | 36896152 | PubTator, text mining | PubMed |
| Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases. | Front Immunol | 2023 | 36875133 | PubTator, text mining | PubMed |
| Periodontal Ehlers-Danlos syndrome in early childhood: A case report of loss of deciduous teeth. | J Indian Soc Periodontol | 2023 | 36873967 | PubTator, text mining | PubMed |
| [Hereditary bradykinin angioedema. Case report]. | Rev Alerg Mex | 2023 | 36869013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=21